
Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>



































| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL1-C5253 | Cynomolgus | Cynomolgus IL-21 Protein, Fc Tag (MALS & SPR verified) | ![]() |
|
|
| IL1-H5113 | Human | Human IL-21 Superior Stable Mutant Protein, premium grade |
|
|
|
| GMP-L21H15 | Human | GMP Human IL-21 Protein (E. coli) | ![]() |
|
|
| IL1-H5114 | Human | Human IL-21 Protein (E. coli), premium grade | ![]() |
|
|
| GMP-L21H25 | Human | GMP Human IL-21 Protein | ![]() |
|
|
| IL1-M52H3 | Mouse | Mouse IL-21 Protein, His Tag | ![]() |
|
|
| CRS-A010 | Human | resDetect™ Human Interleukin-21 (IL-21) ELISA Kit (Residue Testing) | |||
| IL1-C52H9 | Cynomolgus | Cynomolgus IL-21 Protein, His Tag | ![]() |
|
|
| IL1-H5213 | Human | Human IL-21 Protein, premium grade | ![]() |
|
|
| IL1-H5253 | Human | Human IL-21 Protein, Fc Tag | ![]() |
|
|
| IL1-H82F7 | Human | Biotinylated Human IL-21 Protein, Fc,Avitag™, premium grade | ![]() |
|
|

GMP Human IL-21 Protein (Cat. No. GMP-L21H25) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with 10 ng/mL GMP Human IL-15 Protein (Cat. No. GMP-L15H13). The specific activity of GMP Human IL-21 Protein (Cat. No. GMP-L21H25) is > 1ⅹ10^5 U/mg (QC tested).

Human IL-21, premium grade (Cat. No. IL1-H5213) stimulates secretion of IFN-γ by NK-92 human natural killer lymphoma cells stimulated with 10 ng/mL Human IL-15, premium grade (Cat. No. IL5-H4117). The specific activity of Human IL-21, premium grade (Cat. No. IL1-H5213) is > 1ⅹ10^5 U/mg (QC tested).

Biotinylated Human IL-21, Fc,Avitag, premium grade (Cat. No. IL1-H82F7) immobilized on CM5 Chip can bind Human IL-21 R, Fc Tag (Cat. No. ILR-H5257) with an affinity constant of 0.165 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| IL-21 mab (Lilly) | Phase 1 Clinical | Eli Lilly And Company | Immune System Diseases | Details |
This web search service is supported by Google Inc.




